Global Metastatic Lung Adenocarcinoma Treatment Market Size & Outlook
The metastatic lung adenocarcinoma treatment industry worldwide is expected to reach a projected revenue of US$ 9,288.1 million by 2030. A compound annual growth rate of 11.2% is expected of the worldwide metastatic lung adenocarcinoma treatment industry from 2024 to 2030.
Revenue, 2023 (US$M)
$4,406.6
Forecast, 2030 (US$M)
$9,288.1
CAGR, 2024 - 2030
11.2%
Report Coverage
Worldwide
Global metastatic lung adenocarcinoma treatment market, 2018-2030 (US$M)
Related Markets
Global metastatic lung adenocarcinoma treatment market highlights
- The global metastatic lung adenocarcinoma treatment market generated a revenue of USD 4,406.6 million in 2023 and is expected to reach USD 9,288.1 million by 2030.
- The market is expected to grow at a CAGR (2024 - 2030) of 11.2% by 2030.
- In terms of segment, chemotherapy accounted for a revenue of USD 4,406.6 million in 2023.
- Chemotherapy is the most lucrative treatment segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2023.
Global data book summary
| Market revenue in 2023 | USD 4,406.6 million |
| Market revenue in 2030 | USD 9,288.1 million |
| Growth rate | 11.2% (CAGR from 2023 to 2030) |
| Largest segment | Chemotherapy |
| Fastest growing segment | Chemotherapy |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Chemotherapy |
Other key industry trends
- In terms of revenue, the North America accounted for 39.5% of the global metastatic lung adenocarcinoma treatment market in 2023.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Metastatic Lung adenocarcinoma Treatment Market Scope
Metastatic lung adenocarcinoma treatment market segmentation & scope
End Use
Hospitals
Specialty Clinics
Other
Countries
U.S.
Canada
Mexico
UK
Sweden
Spain
Norway
Italy
Germany
France
Denmark
Brazil
Argentina
UAE
Saudi Arabia
South Africa
Kuwait
Thailand
South Korea
Japan
India
China
Metastatic Lung adenocarcinoma Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global metastatic lung adenocarcinoma treatment market size, by regions, 2018-2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
